ResearchTrend.AI
  • Papers
  • Communities
  • Events
  • Blog
  • Pricing
Papers
Communities
Social Events
Terms and Conditions
Pricing
Parameter LabParameter LabTwitterGitHubLinkedInBlueskyYoutube

© 2025 ResearchTrend.AI, All rights reserved.

  1. Home
  2. Papers
  3. 2506.03177
29
0
v1v2 (latest)

Deep Learning-Based Breast Cancer Detection in Mammography: A Multi-Center Validation Study in Thai Population

29 May 2025
Isarun Chamveha
Supphanut Chaiyungyuen
Sasinun Worakriangkrai
Nattawadee Prasawang
Warasinee Chaisangmongkon
Pornpim Korpraphong
Voraparee Suvannarerg
Shanigarn Thiravit
Chalermdej Kannawat
Kewalin Rungsinaporn
Suwara Issaragrisil
Payia Chadbunchachai
Pattiya Gatechumpol
Chawiporn Muktabhant
Patarachai Sereerat
ArXiv (abs)PDFHTML
Main:20 Pages
5 Figures
Bibliography:2 Pages
22 Tables
Abstract

This study presents a deep learning system for breast cancer detection in mammography, developed using a modified EfficientNetV2 architecture with enhanced attention mechanisms. The model was trained on mammograms from a major Thai medical center and validated on three distinct datasets: an in-domain test set (9,421 cases), a biopsy-confirmed set (883 cases), and an out-of-domain generalizability set (761 cases) collected from two different hospitals. For cancer detection, the model achieved AUROCs of 0.89, 0.96, and 0.94 on the respective datasets. The system's lesion localization capability, evaluated using metrics including Lesion Localization Fraction (LLF) and Non-Lesion Localization Fraction (NLF), demonstrated robust performance in identifying suspicious regions. Clinical validation through concordance tests showed strong agreement with radiologists: 83.5% classification and 84.0% localization concordance for biopsy-confirmed cases, and 78.1% classification and 79.6% localization concordance for out-of-domain cases. Expert radiologists' acceptance rate also averaged 96.7% for biopsy-confirmed cases, and 89.3% for out-of-domain cases. The system achieved a System Usability Scale score of 74.17 for source hospital, and 69.20 for validation hospitals, indicating good clinical acceptance. These results demonstrate the model's effectiveness in assisting mammogram interpretation, with the potential to enhance breast cancer screening workflows in clinical practice.

View on arXiv
Comments on this paper